Assessment of p53 and Ki-67 expression in snuff-induced lesions

British Journal of Oral and Maxillofacial Surgery

Volumn 34, Issue 5, 1996, Pages 409-413

  Wedenberg, C ^a   Jonsson A ^a   Hirsch, J M ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; ARTICLE; BIOPSY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; MOUTH MUCOSA; PROTEIN EXPRESSION; SMOKELESS TOBACCO; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029826584     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(96)90097-2     Document Type: Article

References (41)

1. Hoffmann D, Adams JD. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res 1981; 41: 4305-4308.
2. Kirkland LR. The non-smoking use of tobacco. New Engl J Med 1980; 303: 165.
3. Russell MAH, Jarvis MJ, Feyerabend C. A new age for snuff? Lancet 1980; 1: 474-475.
4. Axell T, Mörnstad H, Sundström B. Snusning och munhålecancer-en retrospektiv Studie. Läkartidningen 1978; 75: 2224-2226.
5. Winn DM, Blot WJ, Shy CM, Prickle LW, Toledo Ma, Fraumeni JF Jr. Snuff dipping and oral cancer among women in the Southern United States. New Engl J Med 1981; 304: 745-749.
6. Hirsch JM, Johansson SL. Effect of long-term application of snuff on the oral mucosa-an experimental study in the rat. J Oral Pathol 1983; 12: 187-198.
7. Hirsch JM, Johansson SL, Thilander H, Vahlne A. Effect of long-term application of snuff and herpes simplex virus on rat oral mucosa. Possible association with development of oral cancer. IARC Scientific Publications 1984; 57: 829-836.
8. Johansson SL, Hirsch JM, Larsson PA, Saidi J, Österdahl BG. Snuff-induced carcinogenesis: effect of snuff in rats initiated with 4-nitroquinoline-N-oxide. Cancer Res 1989; 49: 3063-3069.
9. Larsson PA, Johansson SL, Vahlne A, Hirsch JM. Snuff tumourgenesis: effect of longterm snuff administration after initiation with 4-nitroquinoline-N-oxide and herpes simplex virus type 1. J Oral Pathology 1989; 18: 187-192.
10. Parkin DM, Laara E, Muir C. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197.
11. Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T, Scully C, Tedesco B. Epidemiology of mouth cancer in 1989: a review. J R Soc Med 1990; 83: 724-730.
12. Boring CC, Squires TS, Tong T. Cancer statistics 1991. C A 1991; 41: 19-51.
13. La Vecchia C, Franschesci S, Levi F, Lucchini F, Negri E. Diet and human oral cancer in Europe. Oral Oncol, Eur J Cancer 1993; 29b: 1: 17-22.
14. Weinberger RA. Oncogenes, anti-oncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 1989a; 49: 3713-3721.
15. Lane DP, Bendrimol S. p53: oncogene or anti-oncogene? Genes Dev 1990; 4: 1-8.
16. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancer. Science 1991; 253: 49-53.
17. Reihsaus E, Kohler M, Kraiss S, Oren M, Moutenarh M. Regulation of the level of the oncoprotein p53 in nontransformed and transformed cells. Oncogene 1990; 5: 137-145.
18. Bartek J, Bartkova J, Vojtesek B et al. Patterns of expression of the p53 tumour suppressor gene in human breast tissue and tumours in situ and in vitro. Int J Cancer 1990; 46: 839-844.
19. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-1602.
20. Field JK, Spandidos DM, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573-577.
21. Kaur J, Srivastava A, Ralhan R. Overexpression of p53 protein in betel and tobacco related human oral dysplasia and squamous cell carcinoma in India. Int J Cancer 1994; 58: 340-345.
22. Ranasinghe A, Macgeoch C, Dyer S, Spurr N, Johnson NW. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5-9. Anticancer Res 1993; 13: 2065-2068.
23. Langdon JD, Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg 1992; 30: 214-220.
24. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluation in human malignancies. Seminars in cancer biology. 1990; 1: 199-206.
25. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489-503.
26. Levine AJ. The p53 tumour suppressor gene and product. Cancer Surv 1992; 12: 59-79.
27. Barnes DM, Hanby AM, Gillett CE et al. Abnormal expression of wild type p53 in normal cells of cancer family patients. Lancet 1992; 340: 259-263.
28. Warnakulasuriya KAAS, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinomas and potentially malignant oral lesions. J Oral Pathol Med 1992; 21: 404-408.
29. Ogden GR, Kiddie RA, Hunny DP, Lane DP. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol 1992; 166: 389-394.
30. Gustersson BA, Aubazhagen R, Warren W et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-1789.
31. Thompson AM, Anderson TJ, Condoe A et al. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 1992; 50: 528-532.
32. Tadini G, Cerri A, Crosti L, Cattoretti C, Bwrti E. p53 and oncogenes expression in psoriasis. Acta Derm Venereol (Stockh) 1989; 146: 33-35.
33. Fisher CJ, Gillet CE, Vojtesek B, Baunes DM, Millis RR. Problems with p53 immunohistochemical staining: effect of fixation and variation in the methode of evaluation. Br J Cancer 1994; 69: 26-31.
34. Iggo R, Gatter K, Bartek J, Lane DP, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-9.
35. Campell C, Quinn AG, Ro Y-S, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993; 100: 746-748.
36. Nuorva K, Soini Y, Kamel D, et al. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol 1993; 142: 725-732.
37. Sim CS, Slater SD, McKee PH. Mutant p53 is expressed in Bowen's disease. Am J Dermatopathol 1992; 14: 195-199.
38. Cordon-Cardo C, Dalbagni G, Saez G, et al. p53 mutations in human bladder cancer: genotypic versus phenptypic patterns. Int J Cancer 1994; 56: 347-353.
39. Esrig E, Spruck H, Nichols PE, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993; 143: 1389-1397.
40. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
41. Oren M. p53: the ultimate tumor suppressor gene? FASEB J 1992; 6: 3169-3176.